Screening of direct thrombin inhibitors from Radix Salviae Miltiorrhizae by a peak fractionation approach
- 1 May 2015
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 109, 85-90
Abstract
No abstract availableKeywords
Funding Information
- National Scientific Foundation of China (81130068)
- National Scientific Foundation of China (81421005)
- Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 25 references indexed in Scilit:
- Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active componentsActa Pharmacologica Sinica, 2012
- A Series of Natural Flavonoids as Thrombin Inhibitors: Structure-activity relationshipsThrombosis Research, 2010
- New options with dabigatran etexilate in anticoagulant therapyVascular Health and Risk Management, 2010
- Is thrombin a key player in the 'coagulation-atherogenesis' maze?Cardiovascular Research, 2009
- Direct Thrombin InhibitorsNew England Journal of Medicine, 2005
- Multi-component HPLC Fingerprinting of Radix Salviae Miltiorrhizae and Its LC-MS-MS IdentificationChemical and Pharmaceutical Bulletin, 2005
- Small-molecule direct antithrombins: argatrobanBest Practice & Research Clinical Haematology, 2004
- XimelagatranHeart Disease, 2003
- Thrombin signalling and protease-activated receptorsNature, 2000
- Pharmacology of argatrobanExpert Opinion on Investigational Drugs, 1999